Skip to main content

Table 2 Distribution of PankoMabGEX staining patterns

From: Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients

  

Mem-PankoMabGEX

 

Cyt-PankoMabGEX

 

Double negative

Double positive

  

Other

Mem only

 

Other

Cyt only

 

No

Yes

 

No

Yes

 
  

n

(%)

n

(%)

p

n

(%)

n

(%)

p

n

(%)

n

(%)

p

n

(%)

n

(%)

p

Histology

                     
 

NST

79

(34.8)

52

(22.9)

ns

122

(53.7)

9

(4.0)

ns

107

(47.1)

24

(10.6)

0.008

85

(37.4)

46

(20.3)

0.026

 

non NST

57

(25.1)

39

(17.2)

 

92

(40.5)

4

(1.8)

 

63

(27.8)

33

(14.5)

 

76

(33.5)

20

(8.8)

 

Grading

                     
 

G1. G2

59

(37.8)

44

(28.2)

ns

98

(62.8)

5

(3.2)

ns

79

(50.6)

24

(15.4)

ns

73

(46.8)

30

(19.2)

ns

 

G3

34

(21.8

19

(12.2)

 

50

(32.1)

3

(1.9)

 

38

(24.4)

15

(9.6)

 

37

(23.7)

16

(10.3)

 

pT

                     
 

pT1

82

(36.4)

71

(31.6)

0.002

146

(64.9)

7

(3.1)

ns

116

(51.6)

37

(16.4)

ns

115

(51.1)

38

(16.9)

0.041

 

pT2-pT4

54

(24.0)

18

(8.0)

 

66

(29.3)

6

(2.7)

 

52

(23.1)

20

(8.9)

 

44

(19.6)

28

(12.4)

 

pN

                     
 

pN0

62

(28.8)

60

(27.9)

0.001

114

(53.0)

8

(3.7)

ns

96

(44.7)

26

(12.1)

ns

94

(43.7)

28

(13.0)

0.011

 

pN1-pN3

68

(31.6)

25

(11.6)

 

88

(40.9)

5

(2.3)

 

67

(31.2)

26

(12.1)

 

56

(26.0)

37

(17.2)

 

CIS

                     
 

no

65

(28.6)

42

(18.5)

ns

102

(44.9)

5

(2.2)

ns

78

(34.4)

29

(12.8)

ns

76

(33.5)

31

(13.7)

ns

 

yes

71

(31.3)

49

(21.6)

 

112

(49.3)

8

(3.5)

 

92

(40.5)

28

(12.3)

 

85

(37.4)

35

(15.4)

 

ER

                     
 

negative

22

(10.7)

8

(3.9)

ns

29

(14.1)

1

(0.5)

ns

17

(8.3)

13

(6.3)

0.008

22

(10.7)

8

(3.9)

ns

 

positive

99

(48.3)

76

(37.1)

 

165

(80.5)

10

(4.9)

 

141

(68.8)

34

(16.6)

 

120

(58.5)

55

(26.8)

 

PR

                     
 

negative

43

(22.6)

19

(10.0)

0.028

59

(31.1)

3

(1.6)

ns

42

(22.1)

20

(10.5)

0.041

42

(22.1)

20

(10.5)

ns

 

positive

66

(34.7)

62

(32.6)

 

121

(63.7)

7

(3.7)

 

105

(55.3)

23

(12.1)

 

92

(48.4)

36

(18.9)

 

Her2

                     
 

negative

90

(50.0)

70

(38.9)

ns

150

(83.3)

10

(5.6)

ns

119

(66.1)

41

(22.8)

ns

121

(67.2)

39

(21.7)

ns

 

positive

16

(8.9)

4

(2.2)

 

18

(10.0)

2

(1.1)

 

14

(7.8)

6

(3.3)

 

12

(6.7)

8

(4.4)

 

age

                     
 

≤55 y

57

(25.2)

33

(14.6)

ns

85

(37.6)

5

(2.2)

ns

59

(26.1)

31

(13.7)

0.012

69

(30.5)

21

(9.3)

ns

 

>55 y

79

(35.0)

57

(25.2)

 

128

(56.6)

8

(3.5)

 

110

(48.7)

26

(11.5)

 

91

(40.3)

45

(19.9)